{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T01:11:52Z","timestamp":1754183512123,"version":"3.41.2"},"reference-count":13,"publisher":"Japanese Society of Internal Medicine","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,8,1]]},"DOI":"10.2169\/internalmedicine.4759-24","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T17:13:45Z","timestamp":1738343625000},"page":"2394-2398","source":"Crossref","is-referenced-by-count":0,"title":["Unrelated Bone Marrow Transplantation for Chronic Myeloid Leukemia after Liver Transplantation"],"prefix":"10.2169","volume":"64","author":[{"given":"Mirea","family":"Watanabe","sequence":"first","affiliation":[{"name":"Department of Hematology, Nippon Medical School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Marumo","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nippon Medical School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daishi","family":"Onai","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nippon Medical School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meya","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nippon Medical School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuta","family":"Kaito","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nippon Medical School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Asayama","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nippon Medical School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Yui","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nippon Medical School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasunobu","family":"Nagata","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nippon Medical School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Wakita","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nippon Medical School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nippon Medical School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Merrill JP, Murray JE, Harrison JH, Guild WR. Successful homotransplantation of the human kidney between identical twins. J Am Med Assoc 160: 277-282, 1956.","DOI":"10.1001\/jama.1956.02960390027008"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Schladt DP, Israni AK. OPTN\/SRTR 2022 Annual Data Report: Introduction. Am J Transplant 24 (2S1): S10-S18, 2024.","DOI":"10.1016\/j.ajt.2024.01.011"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Acuna SA. Etiology of increased cancer incidence after solid organ transplantation. Transplantation Reviews 32: 218-224, 2018.","DOI":"10.1016\/j.trre.2018.07.001"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Dhanarajan A, Hsu JW, Le Coutre P, Wingard JR, Chang M, Norkin M. Elevated incidence of chronic myeloid leukaemia in immunosuppressed solid organ transplant recipients. Br J Haematol 166: 619-621, 2014.","DOI":"10.1111\/bjh.12885"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Oberender C, Kleeberg L, Nienhues N, et al. Clinical lessons to be learned from patients developing chronic myeloid leukemia while on immunosuppressive therapy after solid organ transplantation: yet another case after orthotopic heart transplantation. Case Rep Hematol 2014: 890438, 2014.","DOI":"10.1155\/2014\/890438"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Thomas ED, Lochte HL, Lu WC, Ferrebee JW. Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. N Engl J Med 257: 491-496, 1957.","DOI":"10.1056\/NEJM195709122571102"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Basak GW, Wiktor-Jedrzejczak W, Labopin M, et al. Allogeneic Hematopoietic Stem Cell Transplantation in Solid Organ Transplant Recipients: A Retrospective, Multicenter Study of the EBMT. American Journal of Transplantation 15: 705-714, 2015.","DOI":"10.1111\/ajt.13017"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Shinohara A, Oshima K, Fuji S, et al. Hematopoietic Stem Cell Transplantation in Solid Organ Recipients with Emphasis on Transplant Complications: A Nationwide Retrospective Survey on Behalf of the Japan Society for Hematopoietic Stem Cell Transplantation Transplant Complications Working Group. Biology of Blood and Marrow Transplantation 26: 66-75, 2020.","DOI":"10.1016\/j.bbmt.2019.08.021"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Hehlmann R, Sau\u00dfele S, Voskanyan A, Silver RT. Management of CML-blast crisis. Best Practice & Research Clinical Haematology 29: 295-307, 2016.","DOI":"10.1016\/j.beha.2016.10.005"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Eder M, Schwarz C, Kammer M, et al. Allograft and patient survival after sequential HSCT and kidney transplantation from the same donor - a multicenter analysis. Am J Transplant 19: 475-487, 2019.","DOI":"10.1111\/ajt.14970"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Jadaun SS, Agarwal S, Gupta S, Saigal S. Strategies for ABO Incompatible Liver Transplantation. J Clin Exp Hepatol 13: 698-706, 2023.","DOI":"10.1016\/j.jceh.2022.12.008"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Sasaki H, Mitani S, Kusumoto S, et al. Pre- and post-transplant ponatinib for a patient with acute megakaryoblastic blast phase chronic myeloid leukemia with T315I mutation who underwent allogeneic hematopoietic stem cell transplantation. Int J Hematol 110: 119-123, 2019.","DOI":"10.1007\/s12185-019-02628-8"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Olavarria E, Siddique S, Griffiths MJ, et al. Posttransplantation imatinib as a strategy to postpone the requirement for immunotherapy in patients undergoing reduced-intensity allografts for chronic myeloid leukemia. Blood 110: 4614-4617, 2007.","DOI":"10.1182\/blood-2007-04-082990"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/15\/64_4759-24\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T04:15:46Z","timestamp":1754108146000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/15\/64_4759-24\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":13,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4759-24","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"type":"print","value":"0918-2918"},{"type":"electronic","value":"1349-7235"}],"subject":[],"published":{"date-parts":[[2025,8,1]]},"article-number":"4759-24"}}